Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the effects of 30 mL intraperitoneal Bupivacaine without epinephrine 0.25% on postoperative pain control in patients undergoing pelvic organ prolapse repair. The investigators hypothesize that use of intraperitoneal Bupivacaine will decrease postoperative pain scores and opiate consumption in the postoperative period, following pelvic organ prolapse repair.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
4.1 Inclusion Criteria
List the criteria:
List the criteria:
Primary purpose
Allocation
Interventional model
Masking
91 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal